Transdermal contraceptive formulations

Details Transdermal contraceptive formulations Transdermal contraceptive formulations

1987-02-26

1989-03-28

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, 424DIG14, 514841, 514874, A61K 1302

Patent

active

048162582

ABSTRACT:
A transdermal delivery system for the administering of ethinyl estradiol and levonorgestrel, in combination, utilizing a polymer matrix having the drug formulation along with a permeation enhancer dispersed throughout.

REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 3948262 (1976-04-01), Zaffaroni
patent: 4144317 (1979-03-01), Higuchi et al.
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4291014 (1981-09-01), Keith et al.
patent: 4314557 (1982-02-01), Chandrasekaran
patent: 4335115 (1982-06-01), Thompson et al.
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4438139 (1984-03-01), Keith et al.
patent: 4568343 (1986-02-01), Leeper et al.
patent: 4624665 (1986-11-01), Nuwayser
Nathke, I., Heller, J. and Baker, R. W., "Transdermal Delivery of Levonorgestrel" published in Proceedings of the 13th International Symposium on Controlled Release of Bioactive Materials (Chaudry, I. and Thies, C. Editors, the Controlled Release Society, Inc.) at pp. 29-30 (1986).

Affiliated with

Also associated with

Rating

Transdermal contraceptive formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal contraceptive formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal contraceptive formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1658091